Figure 1.
Targeting PI3K isoforms with duvelisib, idelalisib, and copanlisib in the tumor and the microenvironment. TAM, tumor-associated macrophage.

Targeting PI3K isoforms with duvelisib, idelalisib, and copanlisib in the tumor and the microenvironment. TAM, tumor-associated macrophage.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal